Fuji Pharma Co., Ltd. (FRA:FUP)
Germany
· Delayed Price · Currency is EUR 8.35
+0.05 (0.60%)
Last updated: Aug 15, 2025
Fuji Pharma Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 14, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Market Capitalization | 206 | 194 | 179 | 177 | 220 | 314 | Upgrade
|
| Market Cap Growth | -5.31% | 8.06% | 1.24% | -19.45% | -30.05% | -9.73% | Upgrade
|
| Enterprise Value | 349 | 358 | 342 | 324 | 287 | 322 | Upgrade
|
| Last Close Price | 8.35 | 7.89 | 6.98 | 6.67 | 8.23 | 8.61 | Upgrade
|
| PE Ratio | 11.36 | 5.04 | 8.25 | 9.32 | 11.68 | 18.67 | Upgrade
|
| PS Ratio | 0.70 | 0.67 | 0.69 | 0.71 | 0.84 | 1.15 | Upgrade
|
| PB Ratio | 0.77 | 0.68 | 0.69 | 0.70 | 0.87 | 0.97 | Upgrade
|
| P/TBV Ratio | 1.03 | 0.94 | 0.92 | 0.99 | 0.94 | 1.05 | Upgrade
|
| P/FCF Ratio | - | 22.54 | - | - | 12.89 | 11.29 | Upgrade
|
| P/OCF Ratio | - | 7.46 | 14.78 | - | 4.74 | 6.75 | Upgrade
|
| EV/Sales Ratio | 1.20 | 1.24 | 1.32 | 1.30 | 1.09 | 1.18 | Upgrade
|
| EV/EBITDA Ratio | - | 7.56 | 7.85 | 7.04 | 6.79 | 7.68 | Upgrade
|
| EV/EBIT Ratio | 11.93 | 14.72 | 14.01 | 12.15 | 11.06 | 12.71 | Upgrade
|
| EV/FCF Ratio | - | 41.61 | - | - | 16.81 | 11.58 | Upgrade
|
| Debt / Equity Ratio | 0.69 | 0.64 | 0.70 | 0.69 | 0.57 | 0.31 | Upgrade
|
| Debt / EBITDA Ratio | - | 3.87 | 4.21 | 3.77 | 3.42 | 2.35 | Upgrade
|
| Debt / FCF Ratio | - | 21.31 | - | - | 8.47 | 3.54 | Upgrade
|
| Asset Turnover | 0.55 | 0.53 | 0.51 | 0.51 | 0.54 | 0.55 | Upgrade
|
| Inventory Turnover | 1.36 | 1.51 | 1.39 | 1.50 | 1.70 | 1.77 | Upgrade
|
| Quick Ratio | 0.76 | 0.66 | 0.63 | 0.68 | 1.10 | 2.16 | Upgrade
|
| Current Ratio | 1.53 | 1.19 | 1.31 | 1.45 | 1.73 | 3.18 | Upgrade
|
| Return on Equity (ROE) | 6.78% | 14.17% | 8.92% | 7.87% | 6.70% | 5.26% | Upgrade
|
| Return on Assets (ROA) | 3.46% | 2.77% | 3.00% | 3.38% | 3.32% | 3.20% | Upgrade
|
| Return on Capital (ROIC) | 4.17% | 3.35% | 3.70% | 4.23% | 4.04% | 3.83% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.20% | 7.20% | 6.90% | 7.30% | 7.60% | 6.20% | Upgrade
|
| Earnings Yield | 8.80% | 19.86% | 12.12% | 10.73% | 8.56% | 5.36% | Upgrade
|
| FCF Yield | - | 4.44% | -4.98% | -22.91% | 7.76% | 8.86% | Upgrade
|
| Dividend Yield | 3.15% | 3.37% | 3.35% | 3.70% | 2.73% | 2.72% | Upgrade
|
| Payout Ratio | - | 15.82% | 26.17% | 27.04% | 33.18% | 43.36% | Upgrade
|
| Buyback Yield / Dilution | -0.25% | -0.04% | -0.03% | 9.58% | 13.77% | -2.06% | Upgrade
|
| Total Shareholder Return | 2.90% | 3.33% | 3.32% | 13.28% | 16.50% | 0.66% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.